Who Paid My Doc
Jeanne Benoit
Nurse Practitioner, Adult Health Quincy, MA Nurse Practitioner
NPI 1942200324 CMS profile 10504329
500 Congress St, Quincy, MA 02169
General payments
$58
Research payments
$0
Ownership & investment interest
$0
Through program year 2023, Jeanne Benoit of Quincy, MA is reported in the CMS Open Payments database as having received $58 across 3 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 17th percentile of Nurse Practitioner, Adult Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | General | $23 | 1 | |
| 2022 | General | $35 | 2 |
Beside peers
- Jeanne Benoit
- Nurse Practitioner, Adult Health median
- Middle half of Nurse Practitioner, Adult Health
- National median
In program year 2025, general payments to Jeanne Benoit were reported at $0. Among 12,696 Nurse Practitioner, Adult Health profiles paid that year, the median was $184 and the middle half received between $59 and $580.
Show as a table
| Year | Jeanne Benoit | Nurse Practitioner, Adult Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $138 | $43–$438 | $132 |
| 2022 | $35 | $165 | $54–$494 | $149 |
| 2023 | $23 | $178 | $61–$549 | $160 |
| 2024 | $0 | $186 | $62–$575 | $164 |
| 2025 | $0 | $184 | $59–$580 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 93 drugsPart D claims
27,820
Drug cost
$6,380,142
Branded share of claims
28.1%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 3,125 | $3,678,743 | |
| Xarelto Rivaroxaban | Brand | 654 | $719,629 | |
| Jardiance Empagliflozin | Brand | 508 | $546,229 | |
| Entresto Sacubitril/Valsartan | Brand | 420 | $512,769 | |
| Repatha Sureclick Evolocumab | Brand | 127 | $130,941 | |
| Brilinta Ticagrelor | Brand | 117 | $100,214 | |
| Metoprolol Succinate | Generic | 4,680 | $98,841 | |
| Praluent Pen Alirocumab | Brand | 80 | $68,452 | |
| Farxiga Dapagliflozin Propanediol | Brand | 57 | $54,727 | |
| Repatha Syringe Evolocumab | Brand | 48 | $46,598 |
The 10 drugs with the highest cost, of 93 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Records
3 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Adult Health in Massachusetts
Krista Tucker
Nurse Practitioner, Adult Health · Boston, MA
Kathleen Dietz Lovett
Nurse Practitioner, Adult Health · Hyannis, MA
Caitlin Reen
Nurse Practitioner, Adult Health · Charlestown, MA
Tiffini Reedy
Nurse Practitioner, Adult Health · Fall River, MA
Christine Agius
Nurse Practitioner, Adult Health · Boston, MA
Amy Pierre
Nurse Practitioner, Adult Health · Jamaica Plain, MA
Related records
Nurse Practitioner, Adult Health in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Adult Health
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.